Quinolone uptake by bacteria and bacterial killing

Reviews of Infectious Diseases

Volumn 11, Issue , 1989, Pages S1413-S1364

  Diver, Jonathan M ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING);

BACTERIUM; DNA REPAIR; DNA REPLICATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

4-QUINOLONES; ANTI-INFECTIVE AGENTS; BACTERIA; BIOLOGICAL TRANSPORT; DNA REPLICATION; DNA TOPOISOMERASES, TYPE II; SOS RESPONSE (GENETICS);

EID: 84960593996     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/11.Supplement_5.S941     Document Type: Article

References (36)

1. Smith JT. Awakening the slumbering potential of the 4-quinolone antibacterials. Pharm J 1984;233:299–305
2. Wolfson JS, Hooper DC. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vivo. Antimicrob Agents Chemother 1985;28:581–6
3. Hirai K, Ito A, Inoue M, Mitsuhashi S. Mode of action of AM-715, a new nalidixic acid analog. Gunna Rep Med Sci 1982;19:375–92
4. Diver JM, Piddock LJV, Wise R. Investigations into the up take of five fluoroquinolones by E. coli [abstract no. 946]. In: Program and abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: Americal Society for Microbiology, 1986
5. Zweerink MM, Edison A. Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone car- boxylic acids. Antimicrob Agents Chemother 1986;29: 598–601
6. Aoyama H, Fujimaki K, Sato K, Fujji T, Inoue M, Hirai K, Mitsuhishi S. Clinical isolate of Citrobacter freundii highly resistant to new quinolones. Antimicrob Agents Chemother 1988;32:922–4
7. Hirai K, Aoyama H, Suzue S, Irikura T, Iyobe S, Mitsuhashi S. Isolation and characterisation of norfloxacin-resistant mutants of Escherichia coli K12. Antimicrob Agents Chemother 1986;30:248–53
8. Hirai K, Suzue S, Irikura T, Iyobe S, Mitsuhashi S. Mutations producing resistance to norfloxacin in Pseudomo- nas aeruginosa. Antimicrob Agents Chemother 1987; 31:582–6
9. Cohen SP, Hooper DC, Wolfson JS, Souza KS, McMurry LM, Levy SB. Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrob Agents Chemother 1988;32:1287–91
10. Piddock LJV, Wise R. Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents. FEMS Microbiology Letters 1987;41:289–94
11. Hirai K, Aoyama H, Irikura T, Iyobe S, Mitsuhashi S. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother 1986;29:535–8
12. Gutmann L, Williamson R, Moreau N, Kitzis M, Collatz E, Acar J, Goldstein FW. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations associated with outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis 1985;151: 501–7
13. Sanders CC, Sanders WE, Goering RV, Werner V. Selection of multiple antibiotic resistance by quinolones, β-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother 1984;26:797–801
14. Chapman JS, Georgopapadakou NH. Routes of quinolone permeation into Escherichia coli. Antimicrob Agents Chemother 1988;32:438–42
15. Bedard J, Wong S, Bryan LE. Accumulation of enoxacin by Escherichia coli and Bacillus subtilis. Antimicrob Agents Chemother 1987;31:1348–54
16. Kotera Y, Kato T, Hirose T, Inoue M, Mitsuhashi S. Mechanism of norfloxacin uptake into Escherichia coli [abstract no. 185]. In: Abstracts of the 15th International Congress of Chemotherapy. Istanbul, Turkey: International Society of Chemotherapy, 1987
17. Diver JM, Piddock LJV, Wise R. Investigations into the mechanism of cell death of E. coli K12 after exposure to quinolone antibacterials [abstract no. 985]. In: Abstracts of the 15th International Congress of Chemotherapy. Istanbul, Turkey: International Society of Chemotherapy, 1987
18. Benbrook DM, Miller RV. Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1986;29:1–6
19. Gellert M, Mizuuchi K, O’Dea MH, Nash HA. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci USA 1976;73:3872–6
20. Cozzarelli NR. DNA gyrase and the supercoiling of DNA. Science 1980;207:953–60
21. Hooper DC, Wolfson JS, Ng EY, Swartz MN. Mechanisms of action and resistance to ciprofloxacin. Am J Med 1987;82(Suppl 4a):12–20
22. Mitsuhashi S. Antibacterial and DNA gyrase inhibitory activity of ciprofloxacin. In: Neu HC, Weuta H, eds. Proceedings of the First International Ciprofloxacin Workshop. Amsterdam: Excerpta Medica, 1985:38–41
23. Domagala JM, Hanna LD, Heifetz CL, Hutt MP, Mich TF, Sanches JP, Solomon M. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J Med Chem 1986;29:394–404
24. Fu KP, Grace ME, McCloud SJ, Gregory FJ, Hung PP. Dis-crepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones. Chemotherapy 1986;32:494–8
25. Shen LL, Pernet AG. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drug is DNA. Proc Natl Acad Sci USA 1985;82:307–11
26. Tabaray X, Moreau N, Dureuil C, LeGoffic F. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and chlorobiocin on Escherichia coli topoisomerase I. Antimicrob Agents Chemother 1987;31:1925–8
27. Goss WA, Deitz WH, Cook TM. Mechanism of action of nalidixic acid on Escherichia coli. II. Inhibition of DNA synthesis. J Bacteriol 1965;89:1068–74
28. Chow RT, Dougherty TJ, Fraimow HS, Beilin EY, Miller MH. Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K12. Antimicrob Agents Chemother 1988;32:1113–8
29. Little JW, Mount DW. The SOS regulatory system of E. coli. Cell 1982;29:11–22
30. Walker GC. Mutagenesis and inducible responses to DNA damage in E. coli. Microbiol Rev 1984;48:60–93
31. Piddock LJV, Wise R. Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents. FEMS Microbiology Letters 1987;41:289–94
32. Phillips I, Culebras E, Moreno F, Baquero F. Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother 1987;20:631–8
33. Diver JM, Wise R. Morphological and biochemical changes in E. coli KL16 after exposure to ciprofloxacin. J Antimicrob Chemother 1986;18(Suppl D):31–41
34. Chin N, Neu HC. Postantibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. Am J Med 1987;82(Suppl 4a):58–62
35. Dougherty TJ, Saukkonen JJ. Membrane permeability changes associated with DNA gyrase inhibitors in Escherichia coli. Antimicrob Agents Chemother 1985;28:200–6
36. Dalhoff A. Interaction of aminoglycosides and ciprofloxacin with bacterial membranes. Zentral Bakteriol Mikrobiol [A] Hyg 1983;253:423–61